share_log

4 Analysts Have This To Say About Maravai LifeSciences

4 Analysts Have This To Say About Maravai LifeSciences

4位分析師對maravai lifesciences的看法
Benzinga ·  12/06 02:00
Throughout the last three months, 4 analysts have evaluated Maravai LifeSciences (NASDAQ:MRVI), offering a diverse set of opinions from bullish to bearish.
在過去的三個月裏,4位分析師對maravai lifesciences(納斯達克:MRVI)進行了評估,給出了從看好到看淡的多種觀點。
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
在下表中,您將找到他們最近的評級摘要,揭示了過去30天內情緒的變化,並將它們與前幾個月進行比較。
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $8.31, with a high estimate of $13.00 and a low estimate of $4.25. Highlighting a 20.86% decrease, the current average has fallen from the previous average price target of $10.50.
分析師對12個月價格目標的評估提供了額外的見解,顯示出平均目標爲8.31美元,最高估計爲13.00美元,最低估計爲4.25美元。當前平均值下降了20.86%,從之前的平均價格目標10.50美元下降。
Understanding Analyst Ratings: A Comprehensive Breakdown
分析師評級:全面解析
The perception of Maravai LifeSciences...
對mara...
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論